Hydroxyzine — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Insomnia (Short-term)

• Doxepin
• Trazodone
• Doxepin 3/6 mg caps
• Trazodone 50/100 mg tabs

Other medications in Respiratory & Allergies

• Ivacaftor
• Levalbuterol
• Levocetirizine
• Lumacaftor-Ivacaftor
• Mepolizumab
• Methylprednisolone IV
• Mometasone
• Mometasone Nasal

What Hydroxyzine is approved for (FDA label)

The total management of anxiety, tension, and psychomotor agitation in conditions of emotional stress requires in most instances a combined approach of psychotherapy and chemotherapy. Hydroxyzine has been found to be particularly useful for this latter phase of therapy in its ability to render the disturbed patient more amenable to psychotherapy in long term treatment of the psychoneurotic and psychotic, although it should not be used as the sole treatment of psychosis or of clearly demonstrated cases of depression. Hydroxyzine is also useful in alleviating the manifestations of anxiety and tension as in the preparation for dental procedures and in acute emotional problems.

Source: Read the full FDA label on DailyMed. Label effective date: October 31, 2025.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Hydroxyzine (FDA label)

Adverse Reactions Therapeutic doses of hydroxyzine seldom produce impairment of mental alertness. However, drowsiness may occur; if so, it is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Dryness of the mouth may be encountered at higher doses. Extensive clinical use has substantiated the absence of toxic effects on the liver or bone marrow when administered in the recommended doses for over four years of uninterrupted therapy. The absence of adverse effects has been further demonstrated in experimental studies in which excessively high doses were administered. Involuntary motor activity, including rare instances of tremor and convulsions, has been reported, usually with doses considerably higher than those recommended.

Source: FDA prescribing information (DailyMed). Set ID: 851e7439-bb0a-4a09-9279-e3c33bff8965. SPL document ID: 5d9b6c38-5a58-4278-999a-f430f34aafd4. Label effective date: October 31, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Hydroxyzine (FDA label)

Contraindications Hydroxyzine hydrochloride intramuscular solution is intended only for intramuscular administration and should not, under any circumstances, be injected subcutaneously, intra­ arterially or intravenously. Hydroxyzine is contraindicated in patients with a prolonged QT interval. This drug is contraindicated for patients who have shown a previous hypersensitivity to it. Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit, induced fetal abnormalities in the rat at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy.

Source: FDA prescribing information (DailyMed). Set ID: 851e7439-bb0a-4a09-9279-e3c33bff8965. SPL document ID: 5d9b6c38-5a58-4278-999a-f430f34aafd4. Label effective date: October 31, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.